Bifrost Biolabs ApS: Financial statements 2019
CVR: 38704001
Source: annual report 2019, Danish Business Authority
01/04/2018 – 31/03/2019
Bifrost Biolabs ApS (CVR 38704001) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 33,485 and a net result of DKK -5,683. Equity in the 2019 report amounted to DKK 23,069. The solvency ratio was 8.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 33,485
- Profit/Loss
- DKK -5,683
- Equity
- DKK 23,069
- Total Assets
- DKK 275,806
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of October 24, 2019, Jan Schouenborg Dombernowsky has left the board of directors of Bifrost Biolabs ApS.
As of July 15, 2019, Jan Schouenborg Dombernowsky has joined the board of directors of Bifrost Biolabs ApS.
As of July 15, 2019, Jesper Møller has joined the board of directors of Bifrost Biolabs ApS.
As of July 15, 2019, Hasse Hedeby has joined the board of directors of Bifrost Biolabs ApS.
As of July 15, 2019, Poul Fogh has joined the board of directors of Bifrost Biolabs ApS.
As of July 15, 2019, Jesper Møller is registered as director of Bifrost Biolabs ApS.
As of July 15, 2019, Hasse Hedeby is registered as director of Bifrost Biolabs ApS.
As of July 15, 2019, Poul Fogh is registered as director of Bifrost Biolabs ApS.
On March 19, 2019, the company changed its name from Recombiotics IVS to Bifrost Biolabs IVS.
About Bifrost Biolabs ApS
Bifrost Biolabs ApS was a Danish company of the type Anpartsselskab based in Glostrup, founded in 2017. The company has been dissolved on 26 July 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named Bifrost Biolabs IVS and Recombiotics IVS. The company has 1 employee (2022). In 2021, the company reported a gross profit of DKK -90,649 and a net result of DKK -421,997 compared with DKK -82,887 the year before. Equity in the 2021 report amounted to DKK -381,762.